Tag: Victoza (liraglutide)

June 20, 2018 Off

Novo Nordisk shows oral semaglutide more effective in lowering glucose and body weight than Victoza

Novo Nordisk on Wednesday said that it has completed headline results of the phase 3a trials PIONEER 4 comparing oral…

August 25, 2017 Off

FDA OK’s Novo Nordisk’s diabetes drug

The U.S. Food and Drug Administration (FDA) has approved a new indication for Novo Nordisk’s Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with type 2 diabetes and established CV disease.